Allianz Asset Management Portfolio holdings
AUM
$74.9B
1-Year Return
18.5%
This Quarter Return
+10.92%
1 Year Return
+18.5%
3 Year Return
+81.04%
5 Year Return
+172.66%
10 Year Return
+376.49%
AUM
$111B
AUM Growth
+$13B
(+13%)
Cap. Flow
-$1.39B
Cap. Flow
% of AUM
-1.25%
Top 10 Holdings %
Top 10 Hldgs %
19.06%
Holding
2,086
New
172
Increased
754
Reduced
706
Closed
156
Top Buys
| 1 |
Noble Corp
NE
|
+$1.32B |
| 2 |
Plug Power
PLUG
|
+$449M |
| 3 |
Schlumberger
SLB
|
+$333M |
| 4 |
UiPath
PATH
|
+$270M |
| 5 |
Zscaler
ZS
|
+$238M |
Top Sells
| 1 |
JPMorgan Chase
JPM
|
+$397M |
| 2 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$330M |
| 3 |
Okta
OKTA
|
+$324M |
| 4 |
Delta Air Lines
DAL
|
+$282M |
| 5 |
Royal Caribbean
RCL
|
+$247M |
Sector Composition
| 1 | Technology | 32% |
| 2 | Healthcare | 11.15% |
| 3 | Consumer Discretionary | 10.74% |
| 4 | Communication Services | 10.72% |
| 5 | Financials | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1626
FormFactor
FORM
$2.3B
| $448K | ﹤0.01% |
12,286
-263,998
| -96% | -$9.63M |
|
1627
Campbell Soup
CPB
$10.1B
| $447K | ﹤0.01% |
9,823
+1,598
| +19% | +$72.7K |
|
1628
Lear
LEA
$5.92B
| $447K | ﹤0.01% |
2,549
-1,844
| -42% | -$323K |
|
1629
Philips
PHG
$26.7B
| $447K | ﹤0.01% |
10,503
-1
| -0% | -$43 |
|
1630
Galicia Financial Group
GGAL
$5.11B
| $445K | ﹤0.01% |
51,592
| – | – |
|
1631
Novanta
NOVT
$4.15B
| $443K | ﹤0.01% |
3,285
| – | – |
|
1632
Nektar Therapeutics
NKTR
$879M
| $441K | ﹤0.01% |
1,711
| – | – |
|
1633
ServisFirst Bancshares
SFBS
$4.69B
| $440K | ﹤0.01% |
6,476
-11,526
| -64% | -$783K |
|
|
ABMD
1634
DELISTED
Abiomed Inc
ABMD
| $435K | ﹤0.01% |
+1,393
| New | +$435K |
|
1635
Cameco
CCJ
$33.6B
| $431K | ﹤0.01% |
22,488
+1,884
| +9% | +$36.1K |
|
|
MTOR
1636
DELISTED
MERITOR, Inc.
MTOR
| $430K | ﹤0.01% |
18,350
-18,350
| -50% | -$430K |
|
|
CCXI
1637
DELISTED
ChemoCentryx, Inc.
CCXI
| $429K | ﹤0.01% |
32,057
+134
| +0.4% | +$1.79K |
|
|
OCDX
1638
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
| $429K | ﹤0.01% |
+20,033
| New | +$429K |
|
1639
Ribbon Communications
RBBN
$722M
| $428K | ﹤0.01% |
+56,201
| New | +$428K |
|
1640
Greif
GEF
$3.53B
| $427K | ﹤0.01% |
7,057
+108
| +2% | +$6.54K |
|
1641
Toro Company
TTC
$7.75B
| $427K | ﹤0.01% |
3,883
-3,993
| -51% | -$439K |
|
1642
Shutterstock
SSTK
$718M
| $425K | ﹤0.01% |
4,329
-2,880
| -40% | -$283K |
|
1643
AudioCodes
AUDC
$279M
| $424K | ﹤0.01% |
12,625
| – | – |
|
1644
VEON
VEON
$3.75B
| $423K | ﹤0.01% |
9,250
-9,968
| -52% | -$456K |
|
1645
Rush Enterprises Class B
RUSHB
$4.5B
| $421K | ﹤0.01% |
16,551
+3,361
| +25% | +$85.5K |
|
1646
Horace Mann Educators
HMN
$1.89B
| $419K | ﹤0.01% |
11,203
+5,602
| +100% | +$210K |
|
1647
Royalty Pharma
RPRX
$15.6B
| $419K | ﹤0.01% |
10,223
+5,260
| +106% | +$216K |
|
1648
Esperion Therapeutics
ESPR
$492M
| $417K | ﹤0.01% |
19,705
-14,640
| -43% | -$310K |
|
1649
Sphere Entertainment
SPHR
$1.87B
| $417K | ﹤0.01% |
4,968
-1,368
| -22% | -$115K |
|
1650
Allogene Therapeutics
ALLO
$246M
| $416K | ﹤0.01% |
+15,965
| New | +$416K |
|